✦ LIBER ✦

Alteration of pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after repeated intravenous administration in dogs

✍ Scribed by L. Iyer; J. Shavit; M. Koza; R. Calabria; S. Moran; J. Fareed

Book ID: 119039257
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 773 KB
Volume: 69
Category: Article
ISSN: 0049-3848
DOI: 10.1016/0049-3848(93)90003-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Studies on the pharmacokinetics and phar

Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs

✍ Lalitha lyer; Michael Koza; Omar Iqbal; Robert Calabria; Jawed Fareed 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 709 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of physostigmine after intravenous administration in beagle dogs

✍ E. Giacobini; S. Somani; M. McIlhany; M. Downen; M. Hallak 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 666 KB

Pharmacokinetics, pharmacodynamics, and

Pharmacokinetics, pharmacodynamics, and analgesic effects of morphine after rectal, intramuscular, and intravenous administration in dogs

✍ Barnhart, Matthew D.; Hubbell, John A. E.; Muir, William W.; Sams, Richard A.; B 📂 Article 📅 2000 🏛 American Veterinary Medicine Association 🌐 English ⚖ 119 KB

Pharmacokinetic and Pharmacodynamic Mode

Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin after Intravenous and Subcutaneous Dose Administration in Cynomolgus Monkeys

✍ Ramakrishnan, R. 📂 Article 📅 2003 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 216 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of L-703,014, a Potent Fibrinogen Receptor Antagonist, After Intravenous and Oral Administration in the Dog

✍ Jeffrey S. Barrett; Robert J. Gould; Joan D. Ellis; Marie M. Holahan; Maria T. S 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 893 KB

THE PHARMACOKINETICS OF 1954U89, 1, 3-DI

THE PHARMACOKINETICS OF 1954U89, 1, 3-DIAMINO-7-(1-ETHYLPROPYL)-8-METHYL-7H-PYRROLO-(3, 2-f )QUINAZOLINE, IN DOGS AND RATS AFTER INTRAVENOUS AND ORAL ADMINISTRATION

✍ S. D. STUDENBERG; J. L. WOOLLEY; D. V. DEANGELIS; W. A. WARGIN 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

1954U89, 1, 3-diamino-7-(1-ethylpropyl)-8-methyl-7H-pyrrolo-(3, 2-f )quinazoline, is a potent, lipid-soluble inhibitor of dihydrofolate reductase. The pharmacokinetics and bioavailability of 1954U89 were examined in male beagle dogs and male CD rats. Dogs received single intravenous (2´5 mg kg 71 )